Literature DB >> 812572

The binding of human and bovine thrombin to human platelets.

M A Shuman, D M Tollefsen, P W Majerus.   

Abstract

Human thrombin binds to specific receptors on the surface of human platelets in a manner analogous to bovine thrombin. Thus, two classes of binding are observed--high affinity with a dissociation constant (Kdiss) of 0.02 U/ml and low affinity with a Kdiss of 5 U/ml. Bovine and human thrombin bind to the same platelet receptors, although bovine thrombin binds with slightly greater affinity. When the amount of thrombin bound to platelets is related to the extent of 14C-serotonin release, bovine and human thrombin are equally effective. Antibodies to human and bovine thrombin were found to differ markedly in their ability to precipitate thrombin of the two species. Thus, antibovine thrombin precipitated eightfold more bovine thrombin than human thrombin, while antihuman thrombin precipitated tenfold more human thrombin than bovine thrombin. Similar differences were found in the ability of Fab fragments of these antibodies to block the interaction of thrombin of each species with human platelets. The finding that both species of thrombin, despite significant evolutionary differences in primary structure, retain essentially identical binding sites to platelets suggests that this part of the thrombin molecule is physiologically important and supports our hypothesis of a role for thrombin binding to platelets in platelet function and hemostasis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 812572

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Thrombin generation and secretion of platelet Factor 4 during blood clotting.

Authors:  M A Shuman; S P Levine
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Role of human factor VIII in factor X activation.

Authors:  M B Hultin
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

3.  Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.

Authors:  M A Shuman; S P Levine
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

4.  Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets.

Authors:  H Holmsen; C A Dangelmaier; S Rongved
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

5.  Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.

Authors:  M Minkes; N Stanford; M M Chi; G J Roth; A Raz; P Needleman; P W Majerus
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

6.  The measurement of thrombin in clotting blood by radioimmunoassay.

Authors:  M A Shuman; P W Majerus
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

7.  Human neutrophil elastase modulates platelet function by limited proteolysis of membrane glycoproteins.

Authors:  M S Brower; R I Levin; K Garry
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis.

Authors:  J Dankert; J van der Werff; S A Zaat; W Joldersma; D Klein; J Hess
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Effect of prevascularization on in vivo vascularization of poly(propylene fumarate)/fibrin scaffolds.

Authors:  Ruchi Mishra; Brianna M Roux; Megan Posukonis; Emily Bodamer; Eric M Brey; John P Fisher; David Dean
Journal:  Biomaterials       Date:  2015-10-22       Impact factor: 12.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.